OSH Insider Trading Activity and SEC Form 4 Filings
OSH insider trading summary
No open-market insider purchases or sales of Oak Street Health, Inc. (OSH) have been reported on SEC Form 4 in the past 12 months.
Latest OSH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 18, 2023 | Geoffrey M Price | Chief Innovation Officer | Sell | $1.9M (50,000 @ $38.88) |
| Apr 10, 2023 | Robert Guenthner | Chief Legal Officer | Sell | $123K (3,169 @ $38.82) |
| Apr 10, 2023 | Geoffrey M Price | Chief Innovation Officer | Sell | $175K (4,517 @ $38.82) |
| Apr 10, 2023 | Timothy M Cook | Chief Financial Officer | Sell | $232K (5,978 @ $38.82) |
| Apr 4, 2023 | Geoffrey M Price | Chief Innovation Officer | Sell | $1.9M (50,000 @ $38.80) |
| Mar 31, 2023 | Geoffrey M Price | Chief Innovation Officer | Sell | $7.7M (200,000 @ $38.69) |
| Mar 31, 2023 | Geoffrey M Price | Chief Innovation Officer | Sell | $9.7M (250,000 @ $38.69) |
| Mar 21, 2023 | Geoffrey M Price | Chief Innovation Officer | Sell | $1.8M (50,000 @ $35.73) |
| Mar 17, 2023 | Geoffrey M Price | Chief Innovation Officer | Sell | $1.4M (37,913 @ $35.63) |
| Mar 16, 2023 | Geoffrey M Price | Chief Innovation Officer | Sell | $2.8M (79,858 @ $35.62) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.